Cell cycle control, genetic instability and cancer;Zellzykluskontrolle, genetische Instabilitat und Krebs

Hautarzt

Volumn 48, Issue 3, 1997, Pages 157-165

  Funk, J O ^a,b,c   Kind, P ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Fred Hutchinson Cancer Research Center   (United States)

^d NONE

Author keywords

apoptosis; cell cycle; checkpoint; cyclins; tumour suppressor genes

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE;

APOPTOSIS; CANCER; CELL CYCLE; DNA SYNTHESIS; GENE EXPRESSION REGULATION; HUMAN; MUTATION; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER; ULTRAVIOLET IRRADIATION; CELL TRANSFORMATION; CHROMOSOME ABERRATION; GENETICS; PHYSIOLOGY; SKIN TUMOR; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; SKIN NEOPLASMS;

EID: 0030895846     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050563     Document Type: Review

References (60)

1. Blount PL, Meltzer SJ, Yin J, Huang Y, Krasna MJ, Reid BJ (1993) Clonal ordering of 17p and Sq allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci USA 90:3221-3225
2. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ (1995) A p53-dependent mouse spindle checkpoint. Science 267.1353-1356
3. Datta R, Hass R, Gunji H, Weichselbaum R, Kufe D (1992) Down-regulation of cell cycle control genes by ionizing radiation. Cell Growth Diff 3:637-644
4. Demers GW, Foster SA, Halbert CL, Galloway DA (1994) Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci USA 91 4382-4386
5. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery JCA, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221
6. Enoch T, Norbury C (1995) Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem Sci 20:426-430
7. Evan GI, Brown L, Whyte M, Harrington E (1995) Apoptosis and the cell cycle. Curr Opinion Cell Biol 7:825-834
8. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
9. Fisher DE (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-542
10. Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Massimo L Beach D (1995) CDC25 phosphatases as potential human oncogenes. Science 269:1575-1577
11. Haffner R, Oren M (1995) Biochemical properties and biological effects of p53. Curr Opion Gen Dev 5:84-90
12. Hartwell LH, Kastan MB (1994) Cell cycle control and cancer. Science 266:1821-1828
13. Hartwell LH, Weinert TA (1989) Checkpoints: controls that ensure the order of cell cycle events. Science 246:629-634
14. Hermeking H, Eick D (1994) Mediation of c-Myc-induced apoptosis by p53. Science 265:2091-2093
15. WAF1/CIPI/SDI1 Oncogene 11.1409-1415
16. Herzinger T, Funk JO, Hillmer K, Eick D, Wolf DA, Kind P (1995) Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase. Oncogene 11:2151-2156
17. HiramaT, Koeffler HP (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841-854
18. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253 49-53
19. Hunter T, Pines J (1994) Cyclinsand cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582
20. Kamb A (1995) Cell-cycle regulators and cancer. Trends Gen 11:136-140
21. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RSI, Johnson BE, Skolnick MH (1994) A cell cycle of regulator potentially involved in genesis of many tumor types. Science 264.436-440
22. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311
23. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380-385
24. Kraemer KH, Levy DD, Parris CN, Gozukara EM, Monwaki S, Adelberg S, Seidman MM (1994) Xeroderma pigmentosum and related disorders: examining the linkage between defective DNA repair and cancer. J Invest Dermatol 103:96-101
25. Kripke ML (1994) Ultraviolet radiation and immunology: something new under the sun. Cancer Res 54:6102-6105
26. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89:7491-7495
27. Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G (1991) D115287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439-444
28. Levine AJ, Momand J, Finlay CA (1991) The p53 tumor suppressor gene. Nature 351:453-456
29. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD (1992) Altered cell cycle arrest and gene amplitication potential accompany loss of wild-type p53. Cell 70.923-935
30. Lu X, Lane DP (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75:765-778
31. Lubbe J, Kleihues P, Burg G (1994) Das Tumorsuppressor-Gen p53 und seine Bedeutung für die Dermatologie. Hautarzt 45:741-745
32. Maity A, McKenna WG, Muschel RJ (1995) Evidence for post-transcriptional regulation of cyctlin C1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J 14:603-609
33. Makela TP, Tassan J-P, Nigg EA, Frutiger S, Hughes GJ, Weinberg RA (1994) A cyclin associated with the CDK-activating kinase M015. Nature 371:254-257
34. Malkin D, Li FP, Strong LC, Fraumeni JJF, Nelson CE, Kim D, Kassel J, Gryka MA, Bischoff FA, Tainsky MA, Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250 1233-1238
35. Massagué J, Polyak K (1995) Mammalian antiproliferative signals and their targets. Curr Opinion Genetics Dev 5:91-96
36. Morgan DO (1995) Principles of CDK regulation. Nature 374:131-134
37. Murnane JP, Schwartz JL (1993) Cell checkpoint and radiosensitivity. Nature 365:22
38. Murray A (1995) Cydin ubiquitination: the destructive end of mitosis. Cell 81:149-152
39. Murray AW (1992) Creative blocks: cell-cycle checkpoints and feedback controls. Nature 359:599-604
40. Norbury C, Nurse P (1992) Animal cell cycles and their control. Annu Rev Biochem 61:441-470
41. Nurse P (1990) Universal control mechanism regulating onset of M-phase. Nature 344.503-508
42. O'Connor PM, Ferris DK, Hoffmann I, Jackman J, Draetta G, Kohn KW (1994) Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. Proc Natl Acad Sci USA 91:9480-9484
43. Palayoor ST, Macklis RM, Bump EA, Coleman CN (1995) Modulation of radiation-induced apoptosis and G2/M block in murine T-lymphoma cells. Radiat Res 141:235-243
44. Paus R, Menrad A, Czarnetzki BM (1995) Nekrobiologie der Haut: Apoptose. Hautarzt 46:285-303
45. Pollock PM, Pearson JV, Hayward NK (1996) Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosom Cancer 15:77-88
46. Reed JA, Loganzo F, Shea CR, Walker GJ, Flores JF, Glendering JM, Bogdany JK, Shiel MJ, Haluska FG, Fountain JW, Albino AP (1995) Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 55.2713-2718
47. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L,Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers HGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y (1995) A single Ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 258:1749-1753
48. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707
49. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho RA (1996) Role of the 1NK4a locus in tumor suppression and cell mortality. Cell 85:27-37
50. Shamanin V, Glover M, Rausch C, Proby C, Leigh IM, zur Hausen H, de Villiers E-M (1994) Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 54:4610-4613
51. Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
52. Smith ML, Chen I-T, Zhan Q, Bae I, Chen C-Y, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ Jr (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266:1376-1380
53. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW, Galloway DA (1996) Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nature Med 2.72-79
54. Wang Y, Prives C (1995) Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376:88-91
55. Weinberg RA (1995) The retinoblastoma protein. Cell 81:323-330
56. Wölfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde K-H, Beach D (1995) A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269:1281-1284
57. Yuspa SH, Dlugosz AA, Cheng CK, Denning MF, Tennenbaum T, Glick AB, Weinberg WC (1994) Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. J Invest Dermatol 103:90S-95S
58. Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA, Goodrow TL (1994) Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 54:5050-5053
59. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelmann J, Remington L, Jacks T, Brash DE (1994) Sunburn and p53 in the onset of skin cancer. Nature 372:773-776
60. zur Hausen H (1991) Viruses in human cancer. Science 254.1167-1173